2-Oxo-4-cyano-1,2-dihydropyridine-3-carboxamides were synthesized. Their antiproliferative activity was studied. They were shown to inhibit slightly the growth of cell lines of lung cancer (a more pronounced tendency for lines A549/ATCC, NCI-H522, and HOP-62); colon cancer (more pronounced for line HCC-2998); brain cancer (for line SNB-19), melanoma (for lines UACC-62, SK-MEL-2, and MALME-3M); kidney cancer (for lines A498 and UO-31); and breast cancer (for lines HS 578T and T-47D).
Similar content being viewed by others
References
J. Prousky, C. G. Millman, and J. B. Kirkland, J. Evidence-Based Integr. Med., 16(2), 88 – 160 (2011).
T. Draper, Indian Physician., 4, 187 – 190 (1945).
N. M. Dmitrieva, N. A. Gorchakova, and R. D. Samilova, Vrach. Delo, 7, 71 – 73 (1972).
G. Brouet and J. Marche, Bull. Med., 66(24), 509 – 515 (1952).
W. M. Eldehna, M. Fares, M. M Abdel-Aziz, et al., Molecules, 20(5), 8800 – 8815 (2015).
B. Toth, Oncology, 38(2), 106 – 109 (1981); doi: https://doi.org/10.1159/00022553.
L. Fania, C. Mazzanti, E. Campione, et al., Int. J. Mol. Sci., 20(23), 5946 – 5963 (2019).
E. S. Hwang and S. B. Song, Cell Mol. Life Sci., 74(18), 3347 – 3362 (2017).
K. Maiese, Curr. Neurovasc. Res., 18(1), 134 – 149 (2021).
Y. Meng, C. Song, Z. Ren, et al., Cell Death Dis., 12(12), 1119 – 1132 (2021).
K. Nakahara, Y. Mitsuoka, S. Kasuya, et al., Eur. J. Med. Chem., 216, 113270 (2021).
L. Gorecki, V. Hepnarova, J. Z. Karasova, et al., Arch Toxicol., 95(3), 985 – 1001 (2021).
H. M. Lee, R. Andrys, J. Jonczyk, et al., J. Enzyme Inhib. Med. Chem., 36(1), 437 – 449 (2021).
R. Mizojiri, D. Tomita, M. Sasaki, et al., Bioorg. Med. Chem., 35, 116056 (2021).
S. D. P. Baugh, M. R. Jackson, A. A. Rashad, et al., Bioorg. Med. Chem. Lett., 54, 128443 (2021).
K. G. Pike, K. Malagu, M. G. Hummersone, et al., Bioorg. Med. Chem. Lett., 23(5), 1212 – 1216 (2013).
Y. Xiao, T. Jin, X. Geng, and X. Zhu, Eur. J. Pharm. Sci., 176, 106241 (2022).
D. S. El-Gamil, A. K. ElHady, P.-J. Chen, et al., Eur. J. Med. Chem., 238, 114411 (2022).
M. J. van Haren, R. Taig, J. Kuppens, et al., Org. Biomol. Chem., 15(31), 6656 – 6667 (2017).
S. Ruf, M. S. Hallur, N. K. Anchan, et al., Bioorg. Med. Chem. Lett., 28(5), 922 – 925 (2018).
C. E. Paul, E. Churakova, E. Maurits, et al., Bioorg. Med. Chem., 22(20), 5692 – 5696 (2014).
J. Yang,W. Pi, L. Xiong, et al., Bioorg. Med. Chem. Lett., 23(5), 1424 – 1427 (2013).
L. Li, Z. Duan, D. Bai, et al., Bioorg. Med. Chem., 40, 116192 (2021).
R.-H. Zhang, D. Yang, X.-M. Liao, et al., Eur. J. Med. Chem., 238, 114469 (2022).
O. Soukup, M. Benkova, R. Dolezal, et al., Eur. J. Med. Chem., 206, 112584 (2020).
C. K. Kedari, N. Roy Choudhury, S. Sharma, et al., ACS Med. Chem. Lett., 5(5), 491 – 495 (2014).
E. Salina, O. Ryabova, A. Kaprelyants, and V. Makarov, Antimicrob. Agents Chemother., 58(1), 55 – 60 (2014).
Y. Jian, F. Hulpia, M. D. P. Risseeuw, et al., Eur. J. Med. Chem., 201, 112450 (2020).
A. Casimiro-Garcia, D. W. Piotrowski, C. Ambler, et al., J. Med. Chem., 57(10), 4273 – 4288 (2014).
S. Munagala, G. Sirasani, P. Kokkonda, et al., Bioorg. Med. Chem., 22(3), 1148 – 1155 (2014).
M. C. Bryan, D. J. Burdick, B. K. Chan, et al., ACS Med. Chem. Lett., 7(1), 100 – 104 (2015).
S. K. Bagal, M. Andrews, B. M. Bechle, et al., J. Med. Chem., 61(15), 6779 – 6800 (2018).
S. Ruf, M. S. Hallur, N. K. Anchan, et al., Bioorg. Med. Chem. Lett., 28(5), 922 – 925 (2018).
S. D. P. Baugh, M. R. Jackson, A. A. Rashad, et al., Bioorg. Med. Chem. Lett., 54, 128443 (2021).
H. Qiu, Z. Ali, J. Bowlan, et al., ChemMedChem, 16(24), 3653 – 3662 (2021).
N. Sakauchi, Y. Kohara, A. Sato, et al., J. Med. Chem., 59(7), 2989 – 3002 (2016).
N. S. El-Gohary and M. I. Shaaban, Arch. Pharm. Chem. Life Sci., 348(9), 666 – 680 (2015).
O. V. Ershov, S. V. Fedoseev, M. Yu. Belikov, and M. Yu. Ievlev, RSC Adv., 5(43), 34191 – 34198 (2015).
S. V. Fedoseev, K. V. Lipin, O. V. Ershov, et al., Russ. J. Org. Chem., 51(8), 1191 – 1193 (2015).
E. G. Nikolaev, O. E. Nasakin, P. B. Terent?ev, et al., Zh. Org. Khim., 20(1), 205 – 206 (1984).
A. Monks, D. Scudiero, P. Skehan, et al., J. Natl. Cancer Inst., 83(11), 757 – 766 (1991).
https://dtp.cancer.gov/discoverydevelopment/nci-60/celllist.htm.
GPM. 1.1.0014.15, State Pharmacopoeia of the Russian Federation, XIVth Ed., Vol. 1 (2018), pp. 319 – 369; http://femb.ru/femb/pharmacopea.ph
S. Sestito, S. Daniele, et al., WO Pat. Appl. 2016198597, Dec. 15, 2016; Chem. Abstr., 198, 124526 (2016).
F. F. Fleming, L. Yao, P. C. Ravikumar, et al., J. Med. Chem., 53, 7902 – 7917 (2010).
M. Isosaki, H. Nakayama, Y. Kyotani, et al., Pharmacol. Rep., 63(3), 733 – 739 (2011).
V. Kuete, M. E. M. Saeed, O. Kadioglu, et al., Phytomedicine, 22(1), 733 – 739 (2011).
W. A. Clarke, E. Chatelut, A. K. Fotoohi, et al., Eur. J. Cancer, 157, 428 – 440 (2021).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 8, pp. 28 – 32, August, 2023.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fedoseev, S.V., Lipin, K.V. Synthesis and Antiproliferative Activity of 2-Oxo-4-Cyano-1,2-Dihydropyridine-3-Carboxamides. Pharm Chem J 57, 1197–1201 (2023). https://doi.org/10.1007/s11094-024-03026-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-024-03026-z